Search results
‘Paxlovid rebound’ raises questions over how long antiviral COVID treatment should last
The Hill via Yahoo News· 2 years agoPresident Biden testing positive for COVID-19 again days after completing a course of Paxlovid has...
For some COVID patients, 'Paxlovid rebound' has nothing to do with Paxlovid
LA Times via Yahoo News· 2 years agoA person holds packets of the antiviral drug Paxlovid. (Stephanie Nano / Associated Press) This is a...
'Rebound' coronavirus cases: What to know after Biden tests positive again
Washington Post via Yahoo News· 2 years agoPresident Joe Biden is one of the latest patients to experience a "rebound" coronavirus infection...
A kitten survived deadly disease after UC Davis experimental trial. Now he needs a home
Sacramento Bee via Yahoo News· 11 months agoExperimental treatment saved a kitten’s life after he was found abandoned at a Sacramento park...
Coronavirus updates for Feb. 23: Here’s what to know in South Carolina this week
The State McClatchy via AOL· 1 year agoWe’re tracking the most up-to-date information about the coronavirus and vaccines in South Carolina....
National Institutes of Health's Long COVID Initiative To Assess Pfizer's Antiviral Pill As Potential...
Benzinga via Yahoo Finance· 2 years agoThe National Institutes of Health's $1 billion RECOVER Initiative has decided to study Pfizer Inc's...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters via Yahoo News· 2 weeks agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
L.A. County facing a full-blown coronavirus surge as cases double, deaths rise
LA Times via Yahoo News· 2 years agoIf coronavirus rates continue to rise, Los Angeles could see a return to indoor mask mandates....
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
Politico via Yahoo News· 1 year agoWhile antiviral pills are plentiful and remain an option for some with weak immune systems, they...
Paxlovid effective in reducing risk of long COVID symptoms: study
The Hill via Yahoo News· 2 years agoA recent preprint study found that Pfizer’s COVID-19 antiviral Paxlovid may be effective in reducing...